Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

InBios International Inc
Profile last edited on: 8/14/2017      CAGE: 3KJL6      UEI: CNJNQ1GMSN55

Business Identifier: In-vitro diagnostic tests for human and veterinary use
Year Founded
1996
First Award
2000
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

562 First Avenue South Suite 600
Seattle, WA 98104
   (206) 344-5821
   info@inbios.com
   www.inbios.com
Location: Single
Congr. District: 07
County: King

Public Profile

InBios International, Inc., a medical diagnostic company, specializes in developing, manufacturing, and marketing in-vitro diagnostic tests for the detection of infectious diseases. The company offers Enzyme Linked Immunosorbent Assay (ELISA) products that can detect diseases such as Leprosy, Filaria, Scrub Typhus, West Nile, Zika Virus, Chagas, Dengue Fever, and Kala Azar. InBios also offers Monoclonal Antibodies and Analyte Specific Reagents. In terms of services, the company offers contract manufacturing and assay development.

Extent of SBIR involvement

User Avatar
Phase I Awards
24
Phase II Awards
15
Conversion Rate
62.50%
Phase I Dollars
$4,290,575
Phase II Dollars
$12,997,528
Total Awarded
$17,288,103

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 2 NIH $598,384
Project Title: Point-Of-Care Antigen Detection Assay for Early Diagnosis of Ebola Virus Disease (EVD)
2021 1 NIH $299,584
Project Title: Development of Next-Gen Chagas Detecttm Plus Rapid Test for Sensitive and Specific Diagnosis of Chagas
2020 2 Army $1,682,272
Project Title: Diagnostic Device for Norovirus Gastroenteritis
2016 2 NIH $2,594,137
Project Title: Antigen Detection Assay for the Diagnosis of Melioidosis
2012 1 NIH $182,430
Project Title: Sensitive And Specific Rapid Diagnostic Test For Acute And Chronic Pancreatitis

Key People / Management

  Ela Raychowdary -- President

  Antonio Campos-Neto

  Raymond L Houghton -- Director of New Product Development

  William John Woodroofe

  Stan Morkowski -- Former Principal Scientist

  John Morrow

  William J W Morrow

  Syamal Raychaudhuri -- CSO

Company News

Aug 27 2013
InBios' Dengue IgM ELISA Continues to Prove Fast and Effective for Presumptive Diagnosis of Dengue Virus Infection